Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio

Pallavi Madhiraju- February 20, 2022 0

Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, ... Read More

GSX Techedu acquires commercial real estate in Zhengzhou, China

Pallavi Madhiraju- February 1, 2020 0

GSX Techedu, an online K-12 large-class after-school tutoring service provider in China, said that it had acquired several commercial real estate plots in the Economics ... Read More